Top Stories
Top Stories
Wires

ASTELLAS PHARMA, SEATTLE GENETICS SAY EXPECT TO FILE FOR U.S. APPROVAL OF ENFORTUMAB VEDOTIN FOR ADVANCED BLADDER CANCER LATER THIS YEAR